Harm A. M. Sinnige

Sequential versus combination chemotherapy with capecitabine, irinotecan, and oxaliplatin in advanced colorectal cancer (CAIRO): a phase III randomised controlled trial

Linda Mol, Miriam Koopman, O. Dalesio, 2007, The Lancet.

Chemotherapy, bevacizumab, and cetuximab in metastatic colorectal cancer.

Linda Mol, Miriam Koopman, O. Dalesio, 2009, The New England journal of medicine.

Effect of thalidomide with melphalan and prednisone on health-related quality of life (HRQoL) in elderly patients with newly diagnosed multiple myeloma: a prospective analysis in a randomized trial

P. Sonneveld, C. U. Uyl‐de Groot, H. Lokhorst, 2011, Annals of Hematology.

High-dose imatinib versus high-dose imatinib in combination with intermediate-dose cytarabine in patients with first chronic phase myeloid leukemia: a randomized phase III trial of the Dutch-Belgian HOVON study group

W. M. Smit, M. Kersten, P. Sonneveld, 2013, Annals of Hematology.